Supplementary Figures S1-S22 from C/EBPa confers dependence to fatty acid anabolic pathways and vulnerability to lipid oxidative stress-induced ferroptosis in FLT3-mutant leukemia Article Swipe

View

Marie Sabatier , Rudy Birsen , Laura Lauture , Sarah Mouche , Paolo Angelino , Jonas Dehairs , Léa Goupille , Ismaël Boussaid , Maël Heiblig , Emeline Boët , Ambrine Sahal , Estelle Saland , Juliana C. Santos , Marc Armengol , Miranda Fernández-Serrano , Thomas Farge , Guillaume Cognet , Federico Simonetta , Corentin Pignon , Antoine Graffeuil , Céline Mazzotti , Hervé Avet‐Loiseau , Océane Delos , Justine Bertrand‐Michel , Amélie Chedru , Vilma Dembitz , Paolo Gallipoli , Natasha S. Anstee , Sun Loo , Andrew H. Wei , Martin Carroll , Armelle Goubard , Rémy Castellano , Yves Collette , François Vergez , Véronique Mansat‐De Mas , Sarah Bertoli , Suzanne Tavitian , Muriel Picard , Christian Récher , Nathalie Bourgès‐Abella , Fanny Granat , Olivier Kosmider , Pierre Sujobert , Benoît Colsch , Carine Joffre , Lucille Stuani , Johannes V. Swinnen , Hervé Guillou , Gaël Roué , Nawad Hakim , Anne S. Dejean , Petros Tsantoulis , Clément Larrue , Didier Bouscary , Jérôme Tamburini , Jean‐Emmanuel Sarry ·

YOU? · · 2024 · Open Access · · DOI: https://doi.org/10.1158/2159-8290.27025463

Supplemental figures S1-S22: Supplementary Figure S1 shows lipid metabolism dependency in FLT3-mutant AML, Supplementary Figure S2 shows anti-leukemic activity of GILT across a panel of AML PDX, Supplementary Figure S3 shows mechanisms of post-translational regulation of C/EBPα expression, Supplementary Figure S4 shows inhibition of C/EBPα phosphorylation and protein expression by FLT3i, Supplementary Figure S5 shows the implication of Ser-21 phosphorylation in post-translational regulation of C/EBPα expression, Supplementary Figure S6 shows that FLT3-ITD regulates the expression of C/EBPα and of proteins related to lipid biosynthesis in AML cell lines, Supplementary Figure S7 shows that FLT3-ITD regulates the expression of genes related to lipid biosynthesis in AML cell lines, Supplementary Figure S8 shows that C/EBPα directly regulates the transcription of lipid biosynthesis genes in AML, Supplementary Figure S9 shows the correlation between CEBPA mRNA expression and FLT3-ITD mutations, Supplementary Figure S10 shows scRNA-seq analysis from PDXTUH84, Supplementary Figure S11 shows scRNA-seq analysis from PDXTUH110, Supplementary Figure S12 shows the evolution of CEBPA_UP and FLT3-ITD_UP signatures in patients with AML treated with GILT, Supplementary Figure S13 shows that C/EBPα regulates rate-limiting lipid biosynthetic enzymes downstream of FLT3-ITD, Supplementary Figure S14 shows that C/EBPα controls lipid amount in FLT3-ITD cell lines, Supplementary Figure S15 shows that FLT3 inhibitors induce a lipid switch increasing neutral lipids dependent on C/EBPα, Supplementary Figure S16 shows that FLT3 inhibitor inhibits fatty acid synthesis fueled by glucose and glutamine, Supplementary Figure S17 shows that FLT3 inhibition decreases monounsaturated fatty acid dependent on C/EBPα, Supplementary Figure S18 shows that FLT3 inhibition increases PUFA/MUFA ratio dependent on C/EBPα, Supplementary Figure S19 shows that ferroptotic cell death induced by FLT3i is mediated by inhibition of SCD-dependent mono-unsaturated FA synthesis, Supplementary Figure S20 shows that FLT3 inhibitors unmask a vulnerability of FLT3-mutant leukemic cells to ferroptosis, Supplementary Figure S21 shows that lipid redox stress induction by GPX4 inhibition primed FLT3i activity in FLT3-ITD AML cells and Supplementary Figure S22 shows combined treatment with GILT and APR-246 in preclinical AML models in vivo.

Related Topics

Concepts

Anabolism Oxidative stress Mutant Chemistry Fatty acid Vulnerability (computing) Cell biology Cancer research Biochemistry Biology Gene Computer science Computer security

Metadata

Type: preprint
Language: en
Landing Page: https://doi.org/10.1158/2159-8290.27025463
OA Status: gold
Related Works: 10
OpenAlex ID: https://openalex.org/W4402804877

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4402804877

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1158/2159-8290.27025463

Digital Object Identifier
Title: Supplementary Figures S1-S22 from C/EBPa confers dependence to fatty acid anabolic pathways and vulnerability to lipid oxidative stress-induced ferroptosis in FLT3-mutant leukemia

Work title
Type: preprint

OpenAlex work type
Language: en

Primary language
Publication year: 2024

Year of publication
Publication date: 2024-09-16

Full publication date if available
Authors: Marie Sabatier, Rudy Birsen, Laura Lauture, Sarah Mouche, Paolo Angelino, Jonas Dehairs, Léa Goupille, Ismaël Boussaid, Maël Heiblig, Emeline Boët, Ambrine Sahal, Estelle Saland, Juliana C. Santos, Marc Armengol, Miranda Fernández-Serrano, Thomas Farge, Guillaume Cognet, Federico Simonetta, Corentin Pignon, Antoine Graffeuil, Céline Mazzotti, Hervé Avet‐Loiseau, Océane Delos, Justine Bertrand‐Michel, Amélie Chedru, Vilma Dembitz, Paolo Gallipoli, Natasha S. Anstee, Sun Loo, Andrew H. Wei, Martin Carroll, Armelle Goubard, Rémy Castellano, Yves Collette, François Vergez, Véronique Mansat‐De Mas, Sarah Bertoli, Suzanne Tavitian, Muriel Picard, Christian Récher, Nathalie Bourgès‐Abella, Fanny Granat, Olivier Kosmider, Pierre Sujobert, Benoît Colsch, Carine Joffre, Lucille Stuani, Johannes V. Swinnen, Hervé Guillou, Gaël Roué, Nawad Hakim, Anne S. Dejean, Petros Tsantoulis, Clément Larrue, Didier Bouscary, Jérôme Tamburini, Jean‐Emmanuel Sarry

List of authors in order
Landing page: https://doi.org/10.1158/2159-8290.27025463

Publisher landing page
Open access: Yes

Whether a free full text is available
OA status: gold

Open access status per OpenAlex
OA URL: https://doi.org/10.1158/2159-8290.27025463

Direct OA link when available
Concepts: Anabolism, Oxidative stress, Mutant, Chemistry, Fatty acid, Vulnerability (computing), Cell biology, Cancer research, Biochemistry, Biology, Gene, Computer science, Computer security

Top concepts (fields/topics) attached by OpenAlex
Cited by: 0

Total citation count in OpenAlex
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W4402804877
doi	https://doi.org/10.1158/2159-8290.27025463
ids.doi	https://doi.org/10.1158/2159-8290.27025463
ids.openalex	https://openalex.org/W4402804877
fwci	0.0
type	preprint
title	Supplementary Figures S1-S22 from C/EBPa confers dependence to fatty acid anabolic pathways and vulnerability to lipid oxidative stress-induced ferroptosis in FLT3-mutant leukemia
biblio.issue
biblio.volume
biblio.last_page
biblio.first_page
topics[0].id	https://openalex.org/T12465
topics[0].field.id	https://openalex.org/fields/13
topics[0].field.display_name	Biochemistry, Genetics and Molecular Biology
topics[0].score	0.9966999888420105
topics[0].domain.id	https://openalex.org/domains/1
topics[0].domain.display_name	Life Sciences
topics[0].subfield.id	https://openalex.org/subfields/1306
topics[0].subfield.display_name	Cancer Research
topics[0].display_name	Cancer, Lipids, and Metabolism
topics[1].id	https://openalex.org/T11297
topics[1].field.id	https://openalex.org/fields/27
topics[1].field.display_name	Medicine
topics[1].score	0.9951000213623047
topics[1].domain.id	https://openalex.org/domains/4
topics[1].domain.display_name	Health Sciences
topics[1].subfield.id	https://openalex.org/subfields/2740
topics[1].subfield.display_name	Pulmonary and Respiratory Medicine
topics[1].display_name	Ferroptosis and cancer prognosis
topics[2].id	https://openalex.org/T11482
topics[2].field.id	https://openalex.org/fields/13
topics[2].field.display_name	Biochemistry, Genetics and Molecular Biology
topics[2].score	0.9746999740600586
topics[2].domain.id	https://openalex.org/domains/1
topics[2].domain.display_name	Life Sciences
topics[2].subfield.id	https://openalex.org/subfields/1312
topics[2].subfield.display_name	Molecular Biology
topics[2].display_name	RNA modifications and cancer
is_xpac	False
apc_list
apc_paid
concepts[0].id	https://openalex.org/C1008401
concepts[0].level	2
concepts[0].score	0.7064673900604248
concepts[0].wikidata	https://www.wikidata.org/wiki/Q184681
concepts[0].display_name	Anabolism
concepts[1].id	https://openalex.org/C2776151105
concepts[1].level	2
concepts[1].score	0.6982161402702332
concepts[1].wikidata	https://www.wikidata.org/wiki/Q898814
concepts[1].display_name	Oxidative stress
concepts[2].id	https://openalex.org/C143065580
concepts[2].level	3
concepts[2].score	0.5681277513504028
concepts[2].wikidata	https://www.wikidata.org/wiki/Q3285695
concepts[2].display_name	Mutant
concepts[3].id	https://openalex.org/C185592680
concepts[3].level	0
concepts[3].score	0.5084337592124939
concepts[3].wikidata	https://www.wikidata.org/wiki/Q2329
concepts[3].display_name	Chemistry
concepts[4].id	https://openalex.org/C543025807
concepts[4].level	2
concepts[4].score	0.4825717508792877
concepts[4].wikidata	https://www.wikidata.org/wiki/Q61476
concepts[4].display_name	Fatty acid
concepts[5].id	https://openalex.org/C95713431
concepts[5].level	2
concepts[5].score	0.4528357684612274
concepts[5].wikidata	https://www.wikidata.org/wiki/Q631425
concepts[5].display_name	Vulnerability (computing)
concepts[6].id	https://openalex.org/C95444343
concepts[6].level	1
concepts[6].score	0.4309975504875183
concepts[6].wikidata	https://www.wikidata.org/wiki/Q7141
concepts[6].display_name	Cell biology
concepts[7].id	https://openalex.org/C502942594
concepts[7].level	1
concepts[7].score	0.37826889753341675
concepts[7].wikidata	https://www.wikidata.org/wiki/Q3421914
concepts[7].display_name	Cancer research
concepts[8].id	https://openalex.org/C55493867
concepts[8].level	1
concepts[8].score	0.3413425385951996
concepts[8].wikidata	https://www.wikidata.org/wiki/Q7094
concepts[8].display_name	Biochemistry
concepts[9].id	https://openalex.org/C86803240
concepts[9].level	0
concepts[9].score	0.258419930934906
concepts[9].wikidata	https://www.wikidata.org/wiki/Q420
concepts[9].display_name	Biology
concepts[10].id	https://openalex.org/C104317684
concepts[10].level	2
concepts[10].score	0.1529083251953125
concepts[10].wikidata	https://www.wikidata.org/wiki/Q7187
concepts[10].display_name	Gene
concepts[11].id	https://openalex.org/C41008148
concepts[11].level	0
concepts[11].score	0.07760927081108093
concepts[11].wikidata	https://www.wikidata.org/wiki/Q21198
concepts[11].display_name	Computer science
concepts[12].id	https://openalex.org/C38652104
concepts[12].level	1
concepts[12].score	0.0
concepts[12].wikidata	https://www.wikidata.org/wiki/Q3510521
concepts[12].display_name	Computer security
keywords[0].id	https://openalex.org/keywords/anabolism
keywords[0].score	0.7064673900604248
keywords[0].display_name	Anabolism
keywords[1].id	https://openalex.org/keywords/oxidative-stress
keywords[1].score	0.6982161402702332
keywords[1].display_name	Oxidative stress
keywords[2].id	https://openalex.org/keywords/mutant
keywords[2].score	0.5681277513504028
keywords[2].display_name	Mutant
keywords[3].id	https://openalex.org/keywords/chemistry
keywords[3].score	0.5084337592124939
keywords[3].display_name	Chemistry
keywords[4].id	https://openalex.org/keywords/fatty-acid
keywords[4].score	0.4825717508792877
keywords[4].display_name	Fatty acid
keywords[5].id	https://openalex.org/keywords/vulnerability
keywords[5].score	0.4528357684612274
keywords[5].display_name	Vulnerability (computing)
keywords[6].id	https://openalex.org/keywords/cell-biology
keywords[6].score	0.4309975504875183
keywords[6].display_name	Cell biology
keywords[7].id	https://openalex.org/keywords/cancer-research
keywords[7].score	0.37826889753341675
keywords[7].display_name	Cancer research
keywords[8].id	https://openalex.org/keywords/biochemistry
keywords[8].score	0.3413425385951996
keywords[8].display_name	Biochemistry
keywords[9].id	https://openalex.org/keywords/biology
keywords[9].score	0.258419930934906
keywords[9].display_name	Biology
keywords[10].id	https://openalex.org/keywords/gene
keywords[10].score	0.1529083251953125
keywords[10].display_name	Gene
keywords[11].id	https://openalex.org/keywords/computer-science
keywords[11].score	0.07760927081108093
keywords[11].display_name	Computer science
language	en
locations[0].id	doi:10.1158/2159-8290.27025463
locations[0].is_oa	True
locations[0].source
locations[0].license	cc-by
locations[0].pdf_url
locations[0].version	acceptedVersion
locations[0].raw_type	posted-content
locations[0].license_id	https://openalex.org/licenses/cc-by
locations[0].is_accepted	True
locations[0].is_published	False
locations[0].raw_source_name
locations[0].landing_page_url	https://doi.org/10.1158/2159-8290.27025463
indexed_in	crossref
authorships[0].author.id	https://openalex.org/A5083840321
authorships[0].author.orcid	https://orcid.org/0000-0001-7673-4842
authorships[0].author.display_name	Marie Sabatier
authorships[0].author_position	first
authorships[0].raw_author_name	Marie Sabatier
authorships[0].is_corresponding	False
authorships[1].author.id	https://openalex.org/A5023772673
authorships[1].author.orcid	https://orcid.org/0000-0001-9696-870X
authorships[1].author.display_name	Rudy Birsen
authorships[1].author_position	middle
authorships[1].raw_author_name	Rudy Birsen
authorships[1].is_corresponding	False
authorships[2].author.id	https://openalex.org/A5073125776
authorships[2].author.orcid	https://orcid.org/0000-0001-7028-6153
authorships[2].author.display_name	Laura Lauture
authorships[2].author_position	middle
authorships[2].raw_author_name	Laura Lauture
authorships[2].is_corresponding	False
authorships[3].author.id	https://openalex.org/A5046308449
authorships[3].author.orcid	https://orcid.org/0000-0002-2348-1746
authorships[3].author.display_name	Sarah Mouche
authorships[3].author_position	middle
authorships[3].raw_author_name	Sarah Mouche
authorships[3].is_corresponding	False
authorships[4].author.id	https://openalex.org/A5037089082
authorships[4].author.orcid	https://orcid.org/0000-0002-1037-2823
authorships[4].author.display_name	Paolo Angelino
authorships[4].author_position	middle
authorships[4].raw_author_name	Paolo Angelino
authorships[4].is_corresponding	False
authorships[5].author.id	https://openalex.org/A5010847260
authorships[5].author.orcid	https://orcid.org/0000-0002-6789-2264
authorships[5].author.display_name	Jonas Dehairs
authorships[5].author_position	middle
authorships[5].raw_author_name	Jonas Dehairs
authorships[5].is_corresponding	False
authorships[6].author.id	https://openalex.org/A5063877554
authorships[6].author.orcid	https://orcid.org/0009-0006-0080-6882
authorships[6].author.display_name	Léa Goupille
authorships[6].author_position	middle
authorships[6].raw_author_name	Lea Goupille
authorships[6].is_corresponding	False
authorships[7].author.id	https://openalex.org/A5036699581
authorships[7].author.orcid	https://orcid.org/0000-0002-1839-8411
authorships[7].author.display_name	Ismaël Boussaid
authorships[7].author_position	middle
authorships[7].raw_author_name	Ismael Boussaid
authorships[7].is_corresponding	False
authorships[8].author.id	https://openalex.org/A5005299934
authorships[8].author.orcid	https://orcid.org/0000-0003-1682-8657
authorships[8].author.display_name	Maël Heiblig
authorships[8].author_position	middle
authorships[8].raw_author_name	Mael Heiblig
authorships[8].is_corresponding	False
authorships[9].author.id	https://openalex.org/A5037383408
authorships[9].author.orcid	https://orcid.org/0000-0002-7718-8692
authorships[9].author.display_name	Emeline Boët
authorships[9].author_position	middle
authorships[9].raw_author_name	Emeline Boet
authorships[9].is_corresponding	False
authorships[10].author.id	https://openalex.org/A5052531237
authorships[10].author.orcid	https://orcid.org/0000-0003-4755-2884
authorships[10].author.display_name	Ambrine Sahal
authorships[10].author_position	middle
authorships[10].raw_author_name	Ambrine Sahal
authorships[10].is_corresponding	False
authorships[11].author.id	https://openalex.org/A5086265821
authorships[11].author.orcid	https://orcid.org/0000-0001-8521-3061
authorships[11].author.display_name	Estelle Saland
authorships[11].author_position	middle
authorships[11].raw_author_name	Estelle Saland
authorships[11].is_corresponding	False
authorships[12].author.id	https://openalex.org/A5058284453
authorships[12].author.orcid	https://orcid.org/0000-0003-4148-9570
authorships[12].author.display_name	Juliana C. Santos
authorships[12].author_position	middle
authorships[12].raw_author_name	Juliana C. Santos
authorships[12].is_corresponding	False
authorships[13].author.id	https://openalex.org/A5010730760
authorships[13].author.orcid	https://orcid.org/0000-0001-5206-9139
authorships[13].author.display_name	Marc Armengol
authorships[13].author_position	middle
authorships[13].raw_author_name	Marc Armengol
authorships[13].is_corresponding	False
authorships[14].author.id	https://openalex.org/A5041695874
authorships[14].author.orcid	https://orcid.org/0000-0001-9040-8496
authorships[14].author.display_name	Miranda Fernández-Serrano
authorships[14].author_position	middle
authorships[14].raw_author_name	Miranda Fernandez-Serrano
authorships[14].is_corresponding	False
authorships[15].author.id	https://openalex.org/A5085586206
authorships[15].author.orcid	https://orcid.org/0000-0002-4390-8073
authorships[15].author.display_name	Thomas Farge
authorships[15].author_position	middle
authorships[15].raw_author_name	Thomas Farge
authorships[15].is_corresponding	False
authorships[16].author.id	https://openalex.org/A5014021738
authorships[16].author.orcid	https://orcid.org/0000-0001-5427-8110
authorships[16].author.display_name	Guillaume Cognet
authorships[16].author_position	middle
authorships[16].raw_author_name	Guillaume Cognet
authorships[16].is_corresponding	False
authorships[17].author.id	https://openalex.org/A5090435126
authorships[17].author.orcid	https://orcid.org/0000-0002-0399-689X
authorships[17].author.display_name	Federico Simonetta
authorships[17].author_position	middle
authorships[17].raw_author_name	Federico Simonetta
authorships[17].is_corresponding	False
authorships[18].author.id	https://openalex.org/A5030443147
authorships[18].author.orcid	https://orcid.org/0009-0006-4083-4167
authorships[18].author.display_name	Corentin Pignon
authorships[18].author_position	middle
authorships[18].raw_author_name	Corentin Pignon
authorships[18].is_corresponding	False
authorships[19].author.id	https://openalex.org/A5088104335
authorships[19].author.orcid	https://orcid.org/0009-0002-6789-1883
authorships[19].author.display_name	Antoine Graffeuil
authorships[19].author_position	middle
authorships[19].raw_author_name	Antoine Graffeuil
authorships[19].is_corresponding	False
authorships[20].author.id	https://openalex.org/A5022060862
authorships[20].author.orcid	https://orcid.org/0009-0001-9858-7895
authorships[20].author.display_name	Céline Mazzotti
authorships[20].author_position	middle
authorships[20].raw_author_name	Celine Mazzotti
authorships[20].is_corresponding	False
authorships[21].author.id	https://openalex.org/A5063422967
authorships[21].author.orcid	https://orcid.org/0000-0002-3050-0140
authorships[21].author.display_name	Hervé Avet‐Loiseau
authorships[21].author_position	middle
authorships[21].raw_author_name	Herve Avet-Loiseau
authorships[21].is_corresponding	False
authorships[22].author.id	https://openalex.org/A5018719838
authorships[22].author.orcid	https://orcid.org/0009-0008-4006-1162
authorships[22].author.display_name	Océane Delos
authorships[22].author_position	middle
authorships[22].raw_author_name	Oceane Delos
authorships[22].is_corresponding	False
authorships[23].author.id	https://openalex.org/A5052176584
authorships[23].author.orcid	https://orcid.org/0000-0001-9815-1517
authorships[23].author.display_name	Justine Bertrand‐Michel
authorships[23].author_position	middle
authorships[23].raw_author_name	Justine Bertrand-Michel
authorships[23].is_corresponding	False
authorships[24].author.id	https://openalex.org/A5009603781
authorships[24].author.orcid	https://orcid.org/0009-0007-3105-3585
authorships[24].author.display_name	Amélie Chedru
authorships[24].author_position	middle
authorships[24].raw_author_name	Amelie Chedru
authorships[24].is_corresponding	False
authorships[25].author.id	https://openalex.org/A5038316031
authorships[25].author.orcid	https://orcid.org/0000-0002-9463-253X
authorships[25].author.display_name	Vilma Dembitz
authorships[25].author_position	middle
authorships[25].raw_author_name	Vilma Dembitz
authorships[25].is_corresponding	False
authorships[26].author.id	https://openalex.org/A5018919552
authorships[26].author.orcid	https://orcid.org/0000-0001-7254-2253
authorships[26].author.display_name	Paolo Gallipoli
authorships[26].author_position	middle
authorships[26].raw_author_name	Paolo Gallipoli
authorships[26].is_corresponding	False
authorships[27].author.id	https://openalex.org/A5060566535
authorships[27].author.orcid	https://orcid.org/0000-0003-2093-1403
authorships[27].author.display_name	Natasha S. Anstee
authorships[27].author_position	middle
authorships[27].raw_author_name	Natasha S. Anstee
authorships[27].is_corresponding	False
authorships[28].author.id	https://openalex.org/A5004675476
authorships[28].author.orcid	https://orcid.org/0000-0001-6294-2691
authorships[28].author.display_name	Sun Loo
authorships[28].author_position	middle
authorships[28].raw_author_name	Sun Loo
authorships[28].is_corresponding	False
authorships[29].author.id	https://openalex.org/A5005591514
authorships[29].author.orcid	https://orcid.org/0000-0002-7514-3298
authorships[29].author.display_name	Andrew H. Wei
authorships[29].author_position	middle
authorships[29].raw_author_name	Andrew H. Wei
authorships[29].is_corresponding	False
authorships[30].author.id	https://openalex.org/A5032477226
authorships[30].author.orcid	https://orcid.org/0000-0002-5622-3735
authorships[30].author.display_name	Martin Carroll
authorships[30].author_position	middle
authorships[30].raw_author_name	Martin Carroll
authorships[30].is_corresponding	False
authorships[31].author.id	https://openalex.org/A5039797032
authorships[31].author.orcid	https://orcid.org/0000-0002-7332-1337
authorships[31].author.display_name	Armelle Goubard
authorships[31].author_position	middle
authorships[31].raw_author_name	Armelle Goubard
authorships[31].is_corresponding	False
authorships[32].author.id	https://openalex.org/A5023548366
authorships[32].author.orcid	https://orcid.org/0000-0002-0152-985X
authorships[32].author.display_name	Rémy Castellano
authorships[32].author_position	middle
authorships[32].raw_author_name	Remy Castellano
authorships[32].is_corresponding	False
authorships[33].author.id	https://openalex.org/A5063779337
authorships[33].author.orcid	https://orcid.org/0000-0001-5359-7099
authorships[33].author.display_name	Yves Collette
authorships[33].author_position	middle
authorships[33].raw_author_name	Yves Collette
authorships[33].is_corresponding	False
authorships[34].author.id	https://openalex.org/A5046461773
authorships[34].author.orcid	https://orcid.org/0000-0002-0063-4404
authorships[34].author.display_name	François Vergez
authorships[34].author_position	middle
authorships[34].raw_author_name	Francois Vergez
authorships[34].is_corresponding	False
authorships[35].author.id	https://openalex.org/A5033024636
authorships[35].author.orcid	https://orcid.org/0000-0003-1878-9129
authorships[35].author.display_name	Véronique Mansat‐De Mas
authorships[35].author_position	middle
authorships[35].raw_author_name	Veronique Mansat-De Mas
authorships[35].is_corresponding	False
authorships[36].author.id	https://openalex.org/A5037378188
authorships[36].author.orcid	https://orcid.org/0000-0003-1084-2781
authorships[36].author.display_name	Sarah Bertoli
authorships[36].author_position	middle
authorships[36].raw_author_name	Sarah Bertoli
authorships[36].is_corresponding	False
authorships[37].author.id	https://openalex.org/A5090936220
authorships[37].author.orcid
authorships[37].author.display_name	Suzanne Tavitian
authorships[37].author_position	middle
authorships[37].raw_author_name	Suzanne Tavitian
authorships[37].is_corresponding	False
authorships[38].author.id	https://openalex.org/A5017187640
authorships[38].author.orcid	https://orcid.org/0000-0002-1749-4276
authorships[38].author.display_name	Muriel Picard
authorships[38].author_position	middle
authorships[38].raw_author_name	Muriel Picard
authorships[38].is_corresponding	False
authorships[39].author.id	https://openalex.org/A5010990164
authorships[39].author.orcid	https://orcid.org/0000-0002-3332-4525
authorships[39].author.display_name	Christian Récher
authorships[39].author_position	middle
authorships[39].raw_author_name	Christian Recher
authorships[39].is_corresponding	False
authorships[40].author.id	https://openalex.org/A5074149966
authorships[40].author.orcid	https://orcid.org/0000-0002-0938-8131
authorships[40].author.display_name	Nathalie Bourgès‐Abella
authorships[40].author_position	middle
authorships[40].raw_author_name	Nathalie Bourges-Abella
authorships[40].is_corresponding	False
authorships[41].author.id	https://openalex.org/A5006591827
authorships[41].author.orcid	https://orcid.org/0000-0003-3026-4501
authorships[41].author.display_name	Fanny Granat
authorships[41].author_position	middle
authorships[41].raw_author_name	Fanny Granat
authorships[41].is_corresponding	False
authorships[42].author.id	https://openalex.org/A5018074362
authorships[42].author.orcid	https://orcid.org/0000-0002-6021-4057
authorships[42].author.display_name	Olivier Kosmider
authorships[42].author_position	middle
authorships[42].raw_author_name	Olivier Kosmider
authorships[42].is_corresponding	False
authorships[43].author.id	https://openalex.org/A5085576247
authorships[43].author.orcid
authorships[43].author.display_name	Pierre Sujobert
authorships[43].author_position	middle
authorships[43].raw_author_name	Pierre Sujobert
authorships[43].is_corresponding	False
authorships[44].author.id	https://openalex.org/A5079805272
authorships[44].author.orcid	https://orcid.org/0000-0002-8023-504X
authorships[44].author.display_name	Benoît Colsch
authorships[44].author_position	middle
authorships[44].raw_author_name	Benoit Colsch
authorships[44].is_corresponding	False
authorships[45].author.id	https://openalex.org/A5034759187
authorships[45].author.orcid	https://orcid.org/0000-0002-7551-356X
authorships[45].author.display_name	Carine Joffre
authorships[45].author_position	middle
authorships[45].raw_author_name	Carine Joffre
authorships[45].is_corresponding	False
authorships[46].author.id	https://openalex.org/A5021453271
authorships[46].author.orcid	https://orcid.org/0000-0001-6116-981X
authorships[46].author.display_name	Lucille Stuani
authorships[46].author_position	middle
authorships[46].raw_author_name	Lucille Stuani
authorships[46].is_corresponding	False
authorships[47].author.id	https://openalex.org/A5016435003
authorships[47].author.orcid	https://orcid.org/0000-0002-7720-5077
authorships[47].author.display_name	Johannes V. Swinnen
authorships[47].author_position	middle
authorships[47].raw_author_name	Johannes V. Swinnen
authorships[47].is_corresponding	False
authorships[48].author.id	https://openalex.org/A5087151365
authorships[48].author.orcid	https://orcid.org/0000-0002-5363-9081
authorships[48].author.display_name	Hervé Guillou
authorships[48].author_position	middle
authorships[48].raw_author_name	Herve Guillou
authorships[48].is_corresponding	False
authorships[49].author.id	https://openalex.org/A5038937943
authorships[49].author.orcid	https://orcid.org/0000-0003-0245-2257
authorships[49].author.display_name	Gaël Roué
authorships[49].author_position	middle
authorships[49].raw_author_name	Gael Roue
authorships[49].is_corresponding	False
has_content.pdf	False
has_content.grobid_xml	False
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://doi.org/10.1158/2159-8290.27025463
open_access.oa_status	gold
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	Supplementary Figures S1-S22 from C/EBPa confers dependence to fatty acid anabolic pathways and vulnerability to lipid oxidative stress-induced ferroptosis in FLT3-mutant leukemia
has_fulltext	False
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic.id	https://openalex.org/T12465
primary_topic.field.id	https://openalex.org/fields/13
primary_topic.field.display_name	Biochemistry, Genetics and Molecular Biology
primary_topic.score	0.9966999888420105
primary_topic.domain.id	https://openalex.org/domains/1
primary_topic.domain.display_name	Life Sciences
primary_topic.subfield.id	https://openalex.org/subfields/1306
primary_topic.subfield.display_name	Cancer Research
primary_topic.display_name	Cancer, Lipids, and Metabolism
related_works	https://openalex.org/W3215508502, https://openalex.org/W2155835698, https://openalex.org/W4211036289, https://openalex.org/W2035326542, https://openalex.org/W2076096978, https://openalex.org/W2884063071, https://openalex.org/W2094337488, https://openalex.org/W2621286599, https://openalex.org/W2163350691, https://openalex.org/W2350587855
cited_by_count	0
locations_count	1
best_oa_location.id	doi:10.1158/2159-8290.27025463
best_oa_location.is_oa	True
best_oa_location.source
best_oa_location.license	cc-by
best_oa_location.pdf_url
best_oa_location.version	acceptedVersion
best_oa_location.raw_type	posted-content
best_oa_location.license_id	https://openalex.org/licenses/cc-by
best_oa_location.is_accepted	True
best_oa_location.is_published	False
best_oa_location.raw_source_name
best_oa_location.landing_page_url	https://doi.org/10.1158/2159-8290.27025463
primary_location.id	doi:10.1158/2159-8290.27025463
primary_location.is_oa	True
primary_location.source
primary_location.license	cc-by
primary_location.pdf_url
primary_location.version	acceptedVersion
primary_location.raw_type	posted-content
primary_location.license_id	https://openalex.org/licenses/cc-by
primary_location.is_accepted	True
primary_location.is_published	False
primary_location.raw_source_name
primary_location.landing_page_url	https://doi.org/10.1158/2159-8290.27025463
publication_date	2024-09-16
publication_year	2024
referenced_works_count	0
abstract_inverted_index.a	22, 205, 285
abstract_inverted_index.FA	275
abstract_inverted_index.S1	5
abstract_inverted_index.S2	15
abstract_inverted_index.S3	29
abstract_inverted_index.S4	40
abstract_inverted_index.S5	53
abstract_inverted_index.S6	68
abstract_inverted_index.S7	90
abstract_inverted_index.S8	109
abstract_inverted_index.S9	125
abstract_inverted_index.by	49, 226, 266, 270, 302
abstract_inverted_index.in	10, 60, 84, 103, 121, 163, 193, 308, 323, 327
abstract_inverted_index.is	268
abstract_inverted_index.of	19, 24, 32, 35, 43, 57, 63, 75, 78, 97, 117, 158, 182, 272, 287
abstract_inverted_index.on	212, 242, 255
abstract_inverted_index.to	81, 100, 291
abstract_inverted_index.AML	25, 85, 104, 166, 310, 325
abstract_inverted_index.S10	138
abstract_inverted_index.S11	146
abstract_inverted_index.S12	154
abstract_inverted_index.S13	172
abstract_inverted_index.S14	186
abstract_inverted_index.S15	199
abstract_inverted_index.S16	216
abstract_inverted_index.S17	232
abstract_inverted_index.S18	246
abstract_inverted_index.S19	259
abstract_inverted_index.S20	279
abstract_inverted_index.S21	295
abstract_inverted_index.S22	315
abstract_inverted_index.and	46, 77, 133, 160, 228, 312, 321
abstract_inverted_index.the	55, 73, 95, 115, 127, 156
abstract_inverted_index.AML,	12, 122
abstract_inverted_index.FLT3	202, 219, 235, 249, 282
abstract_inverted_index.GILT	20, 320
abstract_inverted_index.GPX4	303
abstract_inverted_index.PDX,	26
abstract_inverted_index.acid	223, 240
abstract_inverted_index.cell	86, 105, 195, 263
abstract_inverted_index.from	142, 150
abstract_inverted_index.mRNA	131
abstract_inverted_index.that	70, 92, 111, 174, 188, 201, 218, 234, 248, 261, 281, 297
abstract_inverted_index.with	165, 168, 319
abstract_inverted_index.CEBPA	130
abstract_inverted_index.FLT3i	267, 306
abstract_inverted_index.GILT,	169
abstract_inverted_index.cells	290, 311
abstract_inverted_index.death	264
abstract_inverted_index.fatty	222, 239
abstract_inverted_index.genes	98, 120
abstract_inverted_index.lipid	7, 82, 101, 118, 178, 191, 206, 298
abstract_inverted_index.panel	23
abstract_inverted_index.ratio	253
abstract_inverted_index.redox	299
abstract_inverted_index.shows	6, 16, 30, 41, 54, 69, 91, 110, 126, 139, 147, 155, 173, 187, 200, 217, 233, 247, 260, 280, 296, 316
abstract_inverted_index.FLT3i,	50
abstract_inverted_index.Figure	4, 14, 28, 39, 52, 67, 89, 108, 124, 137, 145, 153, 171, 185, 198, 215, 231, 245, 258, 278, 294, 314
abstract_inverted_index.Ser-21	58
abstract_inverted_index.across	21
abstract_inverted_index.amount	192
abstract_inverted_index.fueled	225
abstract_inverted_index.induce	204
abstract_inverted_index.lines,	87, 106, 196
abstract_inverted_index.lipids	210
abstract_inverted_index.models	326
abstract_inverted_index.primed	305
abstract_inverted_index.stress	300
abstract_inverted_index.switch	207
abstract_inverted_index.unmask	284
abstract_inverted_index.APR-246	322
abstract_inverted_index.C/EBPα	36, 44, 64, 76, 112, 175, 189
abstract_inverted_index.S1-S22:	2
abstract_inverted_index.between	129
abstract_inverted_index.enzymes	180
abstract_inverted_index.figures	1
abstract_inverted_index.glucose	227
abstract_inverted_index.induced	265
abstract_inverted_index.neutral	209
abstract_inverted_index.protein	47
abstract_inverted_index.related	80, 99
abstract_inverted_index.treated	167
abstract_inverted_index.C/EBPα,	213, 243, 256
abstract_inverted_index.CEBPA_UP	159
abstract_inverted_index.FLT3-ITD	71, 93, 134, 194, 309
abstract_inverted_index.activity	18, 307
abstract_inverted_index.analysis	141, 149
abstract_inverted_index.combined	317
abstract_inverted_index.controls	190
abstract_inverted_index.directly	113
abstract_inverted_index.inhibits	221
abstract_inverted_index.leukemic	289
abstract_inverted_index.mediated	269
abstract_inverted_index.patients	164
abstract_inverted_index.proteins	79
abstract_inverted_index.FLT3-ITD,	183
abstract_inverted_index.PDXTUH84,	143
abstract_inverted_index.PUFA/MUFA	252
abstract_inverted_index.decreases	237
abstract_inverted_index.dependent	211, 241, 254
abstract_inverted_index.evolution	157
abstract_inverted_index.increases	251
abstract_inverted_index.induction	301
abstract_inverted_index.inhibitor	220
abstract_inverted_index.regulates	72, 94, 114, 176
abstract_inverted_index.scRNA-seq	140, 148
abstract_inverted_index.synthesis	224
abstract_inverted_index.treatment	318
abstract_inverted_index.PDXTUH110,	151
abstract_inverted_index.dependency	9
abstract_inverted_index.downstream	181
abstract_inverted_index.expression	48, 74, 96, 132
abstract_inverted_index.glutamine,	229
abstract_inverted_index.increasing	208
abstract_inverted_index.inhibition	42, 236, 250, 271, 304
abstract_inverted_index.inhibitors	203, 283
abstract_inverted_index.mechanisms	31
abstract_inverted_index.metabolism	8
abstract_inverted_index.mutations,	135
abstract_inverted_index.regulation	34, 62
abstract_inverted_index.signatures	162
abstract_inverted_index.synthesis,	276
abstract_inverted_index.FLT3-ITD_UP	161
abstract_inverted_index.FLT3-mutant	11, 288
abstract_inverted_index.correlation	128
abstract_inverted_index.expression,	37, 65
abstract_inverted_index.ferroptotic	262
abstract_inverted_index.implication	56
abstract_inverted_index.preclinical	324
abstract_inverted_index.biosynthesis	83, 102, 119
abstract_inverted_index.biosynthetic	179
abstract_inverted_index.ferroptosis,	292
abstract_inverted_index.SCD-dependent	273
abstract_inverted_index.Supplementary	3, 13, 27, 38, 51, 66, 88, 107, 123, 136, 144, 152, 170, 184, 197, 214, 230, 244, 257, 277, 293, 313
abstract_inverted_index.anti-leukemic	17
abstract_inverted_index.rate-limiting	177
abstract_inverted_index.transcription	116
abstract_inverted_index.vulnerability	286
abstract_inverted_index.monounsaturated	238
abstract_inverted_index.phosphorylation	45, 59
abstract_inverted_index.vivo.</p>	328
abstract_inverted_index.mono-unsaturated	274
abstract_inverted_index.post-translational	33, 61
abstract_inverted_index.<p>Supplemental	0
cited_by_percentile_year
countries_distinct_count	0
institutions_distinct_count	57
citation_normalized_percentile.value	0.28172122
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	False